Research

Deep Transcranial Magnetic Stimulation, also known as dTMS therapy, is an FDA-approved treatment which has provided positive outcomes in multiple Brainsway clinical trials for patients suffering from major depressive disorder (MDD), obsessive-compulsive disorder (OCD), mild cognitive impairment (MCI), and smoking cessation. DTMS is a brain stimulation therapy that involves sending magnetic pulses to the brain through coils that are attached to the patient’s head. The treatment is non-invasive; therefore no medical procedures, such as injections, stimulants, surgical treatments, etc., are involved. The approval of a physician, usually a psychiatrist, is required to begin this treatment. Each session lasts about 20 minutes, and most treatments are given five days a week, or as recommended by a psychiatrist. Patients experience intervals of a couple of seconds of intensified stimulation followed by 10 second pauses. Unlike other treatments, dTMS requires no additional medications to be prescribed, other than the ones used currently by the patient. In some cases, patients are required to stop taking specific medication to ensure that there is no interference to the brain stimulation therapy, which is determined on a case to case basis, and is dependent on the patient's cause for treatment (depression, OCD, MCI, or smoking cessation).